Cargando…

Clinical metagenomics

Clinical metagenomic next-generation sequencing (mNGS), the comprehensive analysis of microbial and host genetic material (DNA and RNA) in samples from patients, is rapidly moving from research to clinical laboratories. This emerging approach is changing how physicians diagnose and treat infectious...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiu, Charles Y., Miller, Steven A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858796/
https://www.ncbi.nlm.nih.gov/pubmed/30918369
http://dx.doi.org/10.1038/s41576-019-0113-7
_version_ 1783471030281437184
author Chiu, Charles Y.
Miller, Steven A.
author_facet Chiu, Charles Y.
Miller, Steven A.
author_sort Chiu, Charles Y.
collection PubMed
description Clinical metagenomic next-generation sequencing (mNGS), the comprehensive analysis of microbial and host genetic material (DNA and RNA) in samples from patients, is rapidly moving from research to clinical laboratories. This emerging approach is changing how physicians diagnose and treat infectious disease, with applications spanning a wide range of areas, including antimicrobial resistance, the microbiome, human host gene expression (transcriptomics) and oncology. Here, we focus on the challenges of implementing mNGS in the clinical laboratory and address potential solutions for maximizing its impact on patient care and public health.
format Online
Article
Text
id pubmed-6858796
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-68587962020-03-26 Clinical metagenomics Chiu, Charles Y. Miller, Steven A. Nat Rev Genet Review Article Clinical metagenomic next-generation sequencing (mNGS), the comprehensive analysis of microbial and host genetic material (DNA and RNA) in samples from patients, is rapidly moving from research to clinical laboratories. This emerging approach is changing how physicians diagnose and treat infectious disease, with applications spanning a wide range of areas, including antimicrobial resistance, the microbiome, human host gene expression (transcriptomics) and oncology. Here, we focus on the challenges of implementing mNGS in the clinical laboratory and address potential solutions for maximizing its impact on patient care and public health. Nature Publishing Group UK 2019-03-27 2019 /pmc/articles/PMC6858796/ /pubmed/30918369 http://dx.doi.org/10.1038/s41576-019-0113-7 Text en © Springer Nature Limited 2019 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Review Article
Chiu, Charles Y.
Miller, Steven A.
Clinical metagenomics
title Clinical metagenomics
title_full Clinical metagenomics
title_fullStr Clinical metagenomics
title_full_unstemmed Clinical metagenomics
title_short Clinical metagenomics
title_sort clinical metagenomics
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858796/
https://www.ncbi.nlm.nih.gov/pubmed/30918369
http://dx.doi.org/10.1038/s41576-019-0113-7
work_keys_str_mv AT chiucharlesy clinicalmetagenomics
AT millerstevena clinicalmetagenomics